PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34249258-14	2021	PMX at all doses significantly decreased BDNF serum concentration.	Pramipexole	0-3	brain-derived neurotrophic factor	Rattus norvegicus	41-45	
35463692-3	2022	Compared with that in normal group, the positive expression of BDNF was substantially increased in model group and pramipexole group, and its positive expression in pramipexole group was notably higher than that in model group.	Pramipexole	115-126	brain-derived neurotrophic factor	Rattus norvegicus	63-67	
35463692-3	2022	Compared with that in normal group, the positive expression of BDNF was substantially increased in model group and pramipexole group, and its positive expression in pramipexole group was notably higher than that in model group.	Pramipexole	165-176	brain-derived neurotrophic factor	Rattus norvegicus	63-67	
35463692-8	2022	Pramipexole may up-regulate the expressions of BDNF, miR-103a and miR-30b to inhibit the apoptosis and inflammation in Parkinson"s disease model rats.	Pramipexole	0-11	brain-derived neurotrophic factor	Rattus norvegicus	47-51	
25739024-9	2015	Chronic pramipexole increased BDNF mRNA, but decreased trkB mRNA in the VTA in lesioned rats.	Pramipexole	8-19	brain-derived neurotrophic factor	Rattus norvegicus	30-34	
25739024-11	2015	The present study indicates that both the 6-OHDA-induced dopaminergic lesion and chronic pramipexole influence BDNF signalling in limbic structures, which may be related to their pro-depressive and antidepressant activity in rats, respectively.	Pramipexole	89-100	brain-derived neurotrophic factor	Rattus norvegicus	111-115